JP7279328B2 - drinking composition - Google Patents

drinking composition Download PDF

Info

Publication number
JP7279328B2
JP7279328B2 JP2018183106A JP2018183106A JP7279328B2 JP 7279328 B2 JP7279328 B2 JP 7279328B2 JP 2018183106 A JP2018183106 A JP 2018183106A JP 2018183106 A JP2018183106 A JP 2018183106A JP 7279328 B2 JP7279328 B2 JP 7279328B2
Authority
JP
Japan
Prior art keywords
vitamin
present
derivative
examples
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018183106A
Other languages
Japanese (ja)
Other versions
JP2019062888A (en
Inventor
芳子 本間
幸市朗 櫻井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of JP2019062888A publication Critical patent/JP2019062888A/en
Application granted granted Critical
Publication of JP7279328B2 publication Critical patent/JP7279328B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

本発明は、ビタミンB2若しくはその誘導体又はその塩と多価フェノール化合物を含有した、液剤中に沈殿の生じない飲用組成物に関するものであり、医薬、食品の分野に応用できるものである。 The present invention relates to a drinkable composition containing vitamin B2 or a derivative thereof or a salt thereof and a polyhydric phenol compound, which does not cause sedimentation in a liquid preparation, and can be applied to the fields of medicine and food.

ビタミンB2若しくはその誘導体又はその塩は、口角炎、口内炎、舌炎、口唇炎、結膜炎、角膜炎、急・慢性湿疹、脂漏性皮膚炎等の諸症状の緩和に有効であるほか、肉体疲労時、妊娠・授乳期、病中病後の体力低下時のビタミンB2の補給に用いられている。
多価フェノール化合物は、抗酸化作用を有することが知られており、今までに多価フェノール化合物である没食子酸類を配合してチオクト酸の光安定性を改善した内服液剤やトリプタン化合物の安定性低下を抑制した内服液剤が開示されている(特許文献1~3)。また、ビタミンB1類の不快臭を低減するために、没食子酸類が有用であることも知られている(特許文献4)。
一方で、多価フェノール化合物である没食子酸類は光照射により水に対する溶解度が低い副生成物を生じることが報告されており(非特許文献1)、沈殿の原因となってしまうことが考えられる。
Vitamin B2 or derivatives thereof or salts thereof are effective in relieving various symptoms such as angular stomatitis, stomatitis, glossitis, cheilitis, conjunctivitis, keratitis, acute/chronic eczema, seborrheic dermatitis, etc., and physical fatigue. It is used to supplement vitamin B2 during pregnancy, lactation, and when physical strength is weakened during or after illness.
Polyphenolic compounds are known to have antioxidant properties, and so far, the stability of oral solutions and triptan compounds in which gallic acids, which are polyphenolic compounds, have been added to improve the photostability of thioctic acid has been investigated. Oral liquid preparations that suppress the decrease have been disclosed (Patent Documents 1 to 3). It is also known that gallic acids are useful for reducing the unpleasant odor of vitamin B1s (Patent Document 4).
On the other hand, gallic acids, which are polyhydric phenol compounds, have been reported to produce by-products with low solubility in water upon irradiation with light (Non-Patent Document 1), which may cause precipitation.

特開2004-305089JP 2004-305089 特開2012-36166JP 2012-36166 特開2012-36167JP 2012-36167 特開2004-321178Japanese Patent Application Laid-Open No. 2004-321178

J. Phys. Chem. A., 112, 1188-94 (2008).J. Phys. Chem. A., 112, 1188-94 (2008).

本発明者らは、ビタミンB2若しくはその誘導体又はその塩と多価フェノール化合物である没食子酸若しくはその誘導体又はその塩を含有した飲用組成物は、没食子酸若しくはその誘導体又はその塩の光安定性が大きく低下するという知見を得た。 The present inventors have found that a drinking composition containing vitamin B2 or a derivative thereof or a salt thereof and gallic acid, a derivative thereof, or a salt thereof, which is a polyphenol compound, has a high photostability of gallic acid, a derivative thereof, or a salt thereof. I got the knowledge that it greatly decreases.

したがって、本発明は、飲用組成物中の多価フェノール化合物の光分解を抑制し、沈殿の原因となる副生成物の生成を抑制した飲用組成物を提供することを目的とする。 Accordingly, an object of the present invention is to provide a drink composition that suppresses photodegradation of polyhydric phenol compounds in the drink composition and suppresses the formation of by-products that cause precipitation.

本発明者らは、上記課題を解決すべく鋭意検討した結果、二酸化炭素を含有させた場合に、多価フェノール化合物である没食子酸若しくはその誘導体又はその塩の光分解が抑制されることを見出し、本発明を完成した。 As a result of intensive studies to solve the above problems, the present inventors found that photodecomposition of gallic acid, a derivative thereof, or a salt thereof, which is a polyhydric phenol compound, is suppressed when carbon dioxide is contained. , completed the present invention.

即ち本発明は、
(1)a) ビタミンB2若しくはその誘導体又はその塩、b) ビタミンB2若しくはその誘導体又はその塩の1質量部に対して0.02~2.5質量部の多価フェノール化合物、及びc) 二酸化炭素をガス内圧で1.0~4.0kg/cm2含有する飲用組成物、
(2)ビタミンB2若しくはその誘導体又はその塩が、リボフラビン、リン酸リボフラビン、酪酸リボフラビン、フラビンアデニンヌクレオチド及びこれらの塩からなる群から選ばれる少なくとも一種である(1)に記載の飲用組成物、
(3)多価フェノール化合物が没食子酸プロピルである(1)に記載の飲用組成物、
(4)449nmの光透過率が0.1%以上である容器に充填した(1)~(3)のいずれかに記載の飲用組成物、
である。
That is, the present invention
(1) a) vitamin B2 or its derivative or its salt, b) 0.02 to 2.5 parts by mass of a polyhydric phenol compound per 1 part by mass of vitamin B2 or its derivative or its salt, and c) dioxide A drinking composition containing carbon at an internal gas pressure of 1.0 to 4.0 kg/cm 2 ,
(2) The beverage composition according to (1), wherein the vitamin B2 or a derivative thereof or a salt thereof is at least one selected from the group consisting of riboflavin, riboflavin phosphate, riboflavin butyrate, flavin adenine nucleotides and salts thereof;
(3) The drinking composition according to (1), wherein the polyhydric phenol compound is propyl gallate;
(4) The drinking composition according to any one of (1) to (3) filled in a container having a light transmittance of 0.1% or more at 449 nm,
is.

本発明により、ビタミンB2若しくはその誘導体又はその塩と多価フェノール化合物を含有した飲用組成物に、二酸化炭素を含有させることで、液中の沈殿生成を抑制した飲用組成物を提供することが可能になった。 INDUSTRIAL APPLICABILITY According to the present invention, it is possible to provide a drinking composition that suppresses precipitation in liquid by adding carbon dioxide to a drinking composition containing vitamin B2 or a derivative thereof or a salt thereof and a polyhydric phenol compound. Became.

本発明に使用するビタミンB2若しくはその誘導体又はその塩とは、通常可食性のものを指し、具体的にはリボフラビン、リン酸リボフラビン、酪酸リボフラビン、フラビンアデニンヌクレオチド及びそれらの塩などをあげることができる。本発明におけるビタミンB2若しくはその誘導体又はその塩の含有量は、特に限定されないが、栄養摂取量の面からリボフラビンに換算して、1日当たり0.01~100mgが好ましく、0.33~30mgがより好ましく、2~30mgがさらに好ましい。飲用組成物におけるリボフラビンの含有量は、0.00001~1w/v%が好ましく、0.00033~0.3w/v%がより好ましく、0.002~0.3w/v%がさらに好ましい。 Vitamin B2 or derivatives thereof or salts thereof used in the present invention refer to edible ones, and specific examples thereof include riboflavin, riboflavin phosphate, riboflavin butyrate, flavin adenine nucleotide and salts thereof. . The content of vitamin B2 or a derivative thereof or a salt thereof in the present invention is not particularly limited. Preferably, 2 to 30 mg is more preferable. The content of riboflavin in the drink composition is preferably 0.00001 to 1 w/v%, more preferably 0.00033 to 0.3 w/v%, even more preferably 0.002 to 0.3 w/v%.

本発明に用いる多価フェノール化合物とは、通常可食性のものを指し、特に限定されないが、没食子酸若しくはその誘導体又はその塩が好ましい。より好ましくは、没食子酸、没食子酸メチル、没食子酸エチル、没食子酸プロピル、没食子酸ブチル及びそれらの塩であり、さらに好ましくは没食子酸メチル、没食子酸エチル、没食子酸プロピル、没食子酸ブチルである。本発明における多価フェノールの含有量は、ビタミンB2若しくはその誘導体又はその塩の光安定性確保の面から、ビタミンB2若しくはその誘導体又はその塩1質量部に対して0.02~2.5質量部であり、好ましくは0.06~2.0質量部であり、さらに好ましくは0.06~1.3質量部である。 The polyhydric phenol compound used in the present invention generally refers to edible compounds and is not particularly limited, but gallic acid, derivatives thereof, or salts thereof are preferred. Gallic acid, methyl gallate, ethyl gallate, propyl gallate, butyl gallate and salts thereof are more preferred, and methyl gallate, ethyl gallate, propyl gallate and butyl gallate are more preferred. The content of the polyhydric phenol in the present invention is 0.02 to 2.5 parts by mass with respect to 1 part by mass of vitamin B2 or its derivative or its salt from the viewpoint of ensuring the photostability of vitamin B2 or its derivative or its salt. parts, preferably 0.06 to 2.0 parts by mass, more preferably 0.06 to 1.3 parts by mass.

本発明に用いる二酸化炭素は、通常食品や医薬品に用いられるものを指す。二酸化炭素としては、二酸化炭素を単独で使用するものであっても、二酸化炭素とそれ以外の酸素、水素、窒素等のガス類とを2種類以上混合するものであってよいが、二酸化炭素を単独で用いることが好ましい。二酸化炭素の含有量は、飲用組成物全体に対するガス内圧(単位体積中に溶解しているガス量)として、1.0~4.0kg/cmであるが、1.3~3.8kg/cmがより好ましい。 The carbon dioxide used in the present invention refers to those commonly used in foods and pharmaceuticals. As carbon dioxide, carbon dioxide may be used alone, or a mixture of two or more kinds of carbon dioxide and other gases such as oxygen, hydrogen, nitrogen, etc. may be used. It is preferable to use it alone. The content of carbon dioxide is 1.0 to 4.0 kg/cm 2 , but 1.3 to 3.8 kg/cm as an internal gas pressure (the amount of gas dissolved in a unit volume) of the entire drinking composition. cm 2 is more preferred.

本発明に用いる容器は、449nmの光透過率が0.1%以上であることが好ましく、より好ましくは0.2%以上である。具体的には、透明ガラス瓶や褐色あるいは茶系のガラス瓶などが挙げられる。容器の材質は、特に制限がなく、例えばガラス製、プラスティック製等が挙げられる。 The container used in the present invention preferably has a light transmittance of 0.1% or more at 449 nm, more preferably 0.2% or more. Specifically, transparent glass bottles, brown or brownish glass bottles, and the like can be used. The material of the container is not particularly limited, and examples thereof include glass and plastic.

本発明にかかる飲用組成物のpHは、特に限定されず、例えば、2.0~7.0である。風味の観点からは低pHであることが好ましく、さらに好ましくは2.5~5.5である。本発明の飲用組成物のpH調整は、通常使用されるpH調整剤を使用することができる。具体的なpH調整剤としては、クエン酸、リンゴ酸、酒石酸、コハク酸、乳酸、酢酸、マレイン酸、グルコン酸、アスパラギン酸、アジピン酸、グルタミン酸、フマル酸等の有機酸及びそれらの塩類、塩酸等の無機酸、水酸化ナトリウムなどの無機塩基等が挙げられる。 The pH of the drink composition according to the present invention is not particularly limited, and is, for example, 2.0 to 7.0. From the standpoint of flavor, the pH is preferably low, more preferably 2.5 to 5.5. A commonly used pH adjuster can be used to adjust the pH of the drink composition of the present invention. Specific pH adjusters include organic acids such as citric acid, malic acid, tartaric acid, succinic acid, lactic acid, acetic acid, maleic acid, gluconic acid, aspartic acid, adipic acid, glutamic acid, and fumaric acid, salts thereof, and hydrochloric acid. and inorganic bases such as sodium hydroxide.

本発明の飲用組成物にはその他の成分として、他のビタミン類、ミネラル類、アミノ酸及びその塩類、他の生薬や生薬抽出物、カフェインなどを本発明の効果を損なわない範囲で適宜に配合することができる。 Other ingredients such as vitamins, minerals, amino acids and their salts, other herbal medicines and herbal extracts, caffeine, etc., are appropriately blended in the beverage composition of the present invention as long as they do not impair the effects of the present invention. can do.

さらに必要に応じて、甘味料、酸味料、増粘安定剤、酸化防止剤、着色剤、香料、矯味剤、保存料、調味料、苦味料、強化剤、可溶化剤、乳化剤などの添加物を本発明の効果を損なわない範囲で適宜に配合することができる。 Additives such as sweeteners, acidulants, thickeners, antioxidants, coloring agents, flavors, corrigents, preservatives, seasonings, bittering agents, enhancers, solubilizers, emulsifiers, etc. can be appropriately blended within a range that does not impair the effects of the present invention.

本発明の飲用組成物は、常法により調製することができ、その方法は特に限定されるものではない。通常、各成分をとり適量の精製水で溶解した後、pHを調整し、残りの精製水を加えて容量調製し、必要に応じてろ過、殺菌処理し得られた飲料原液を冷却した後、ガス圧が所定の範囲、例えば、1.0~4.0kg/cmになるように炭酸ガスをガス封入(カーボネーション)し、容器に充填する工程により製造することができる。なお、炭酸飲料の製法には、プレミックス法とポストミックス法とがあるが、本発明においてはいずれを採用してもよい。 The drink composition of the present invention can be prepared by a conventional method, and the method is not particularly limited. Usually, each component is taken and dissolved in an appropriate amount of purified water, then the pH is adjusted, the remaining purified water is added to adjust the volume, filtered and sterilized as necessary, and the resulting beverage concentrate is cooled, It can be produced by a process of charging carbon dioxide gas into a container so that the gas pressure is in a predetermined range, for example, 1.0 to 4.0 kg/cm 2 , and filling the container. There are a premix method and a postmix method for producing carbonated beverages, and either method may be employed in the present invention.

本発明の飲用組成物は、例えばシロップ剤、ドリンク剤などの医薬品や医薬部外品などの各種製剤、健康飲料などの各種飲料に適用することができる。 The drinkable composition of the present invention can be applied to, for example, pharmaceuticals such as syrups and drinks, various formulations such as quasi-drugs, and various beverages such as health drinks.

以下に実施例、比較例及び試験例を挙げ、本発明をさらに詳しく説明する。 The present invention will be described in more detail below with reference to examples, comparative examples and test examples.

(実施例1~3、比較例1~2)
リボフラビンリン酸エステルナトリウム5mg、没食子酸プロピル2mg、安息香酸ナトリウム60mg、クエン酸500mgを精製水に溶解し、二酸化炭素をガス内圧でそれぞれ、1.3kg/cm、2.4kg/cm、3.8kg/cmになるように調整した炭酸水で全量を100mLとした。この液を洗浄した449nmの光透過率が0.1%の褐色ガラスビンに充填し、キャッピングしたものを内服液剤とした。
以下の比較例1、比較例2は、炭酸水を精製水に変更し、その他は実施例1~3と同様に調製した。それぞれの処方を表1に示す。
(Examples 1-3, Comparative Examples 1-2)
5 mg of sodium riboflavin phosphate, 2 mg of propyl gallate, 60 mg of sodium benzoate, and 500 mg of citric acid were dissolved in purified water, and carbon dioxide was added at internal gas pressures of 1.3 kg/cm 2 , 2.4 kg/cm 2 , and 3, respectively. Carbonated water adjusted to 0.8 kg/cm 2 was added to bring the total volume to 100 mL. This solution was filled into a washed brown glass bottle having a light transmittance of 0.1% at 449 nm and capped to prepare an internal solution.
Comparative Examples 1 and 2 below were prepared in the same manner as in Examples 1 to 3 except that the carbonated water was changed to purified water. Each formulation is shown in Table 1.

Figure 0007279328000001
Figure 0007279328000001

(実施例4~12、比較例3~8)
実施例1~3、比較例1~2と同様に、表2~7の処方に従って、実施例4~12、比較例3~8の内服液剤を調製した。
(Examples 4-12, Comparative Examples 3-8)
In the same manner as in Examples 1-3 and Comparative Examples 1-2, oral solutions of Examples 4-12 and Comparative Examples 3-8 were prepared according to the formulations in Tables 2-7.

Figure 0007279328000002
Figure 0007279328000002

Figure 0007279328000003
Figure 0007279328000003

Figure 0007279328000004
Figure 0007279328000004

Figure 0007279328000005
Figure 0007279328000005

Figure 0007279328000006
Figure 0007279328000006

Figure 0007279328000007
Figure 0007279328000007

(試験例1:没食子酸プロピルの光安定性試験)
実施例1~3、6~12、比較例1及び比較例2、比較例5~8で得た内服液剤を3000Lux×200時間曝光させた。実施例4及び実施例5、比較例3及び比較例4で得た内服液剤は3000Lux×60時間曝光させた。これらの内服液剤中の没食子酸プロピル残存率を液体クロマトグラフ法(カラム:ODS-80TS(東ソー)、移動相:水:アセトニトリル:酢酸=800:170:30、流速:1mL/min、検出波長:280nm)により定量した。調製直後に対する3000Lux×200時間曝光後または3000Lux×60時間曝光後の没食子酸プロピル残存率(%)を表1~7に示す。
(Test Example 1: Photostability test of propyl gallate)
The oral solutions obtained in Examples 1 to 3, 6 to 12, Comparative Examples 1 and 2, and Comparative Examples 5 to 8 were exposed to light of 3000 Lux for 200 hours. The oral liquid preparations obtained in Examples 4 and 5 and Comparative Examples 3 and 4 were exposed to light for 3000 Lux×60 hours. The residual ratio of propyl gallate in these oral solutions was measured by liquid chromatography (column: ODS-80TS (Tosoh), mobile phase: water: acetonitrile: acetic acid = 800: 170: 30, flow rate: 1 mL/min, detection wavelength: 280 nm). Tables 1 to 7 show the propyl gallate residual rate (%) after exposure to 3000 Lux×200 hours or after exposure to 3000 Lux×60 hours compared to immediately after preparation.

表1から明らかなように、比較例1と比較例2より、リボフラビンリン酸エステルナトリウム存在下では没食子酸プロピルの光安定性が大きく低下した。実施例1~3は比較例2と比較して没食子酸プロピルの光安定性が改善されていた。
実施例4は比較例3と比較して没食子酸プロピルの光安定性が改善されていた。実施例5は比較例4と比較して没食子酸プロピルの光安定性が改善されていた。実施例6は比較例5と比較して没食子酸プロピルの光安定性が改善されていた。実施例7及び実施例8は比較例6と比較して没食子酸プロピルの光安定性が改善されていた。実施例9及び実施例10は比較例7と比較して没食子酸プロピルの光安定性が改善されていた。実施例11及び実施例12は比較例8と比較して没食子酸プロピルの光安定性が改善されていた。
これら結果から二酸化炭素を含有させることにより、リボフラビンリン酸エステルが含有された際に生じる没食子酸プロピルの光安定性低下を改善できることが明らかとなった。
As is clear from Table 1, compared to Comparative Examples 1 and 2, the photostability of propyl gallate in the presence of sodium riboflavin phosphate was greatly reduced. Examples 1-3 had improved photostability of propyl gallate compared to Comparative Example 2.
Example 4 had improved photostability of propyl gallate compared to Comparative Example 3. Example 5 had improved photostability of propyl gallate compared to Comparative Example 4. Example 6 had improved photostability of propyl gallate compared to Comparative Example 5. Examples 7 and 8 had improved photostability of propyl gallate compared to Comparative Example 6. Examples 9 and 10 had improved photostability of propyl gallate compared to Comparative Example 7. Examples 11 and 12 had improved photostability of propyl gallate compared to Comparative Example 8.
From these results, it was clarified that the inclusion of carbon dioxide can improve the decrease in photostability of propyl gallate that occurs when riboflavin phosphate is included.

本発明によりビタミンB2類を安定に含有し、沈殿の生じない内服液剤を得ることができ、医薬品、食品、健康飲料、特定保健用食品などに使用可能である。 According to the present invention, it is possible to obtain a liquid preparation for internal use that stably contains vitamin B2 and does not cause precipitation, and can be used for pharmaceuticals, foods, health drinks, foods for specified health uses, and the like.

Claims (2)

a)リボフラビン、リン酸リボフラビン、酪酸リボフラビン、フラビンアデニンヌクレオチドからなる群から選ばれる少なくとも一種であるビタミンB2若しくはその誘導体又はその塩、b)ビタミンB2若しくはその誘導体又はその塩の1質量部に対して0.02~2.5質量部の没食子酸プロピル、及びc)二酸化炭素をガス内圧で1.0~4.0kg/cm2含有し、キャッピング容器に充填された飲用組成物。 a) vitamin B2 or a derivative thereof or a salt thereof, which is at least one selected from the group consisting of riboflavin, riboflavin phosphate, riboflavin butyrate, and flavin adenine nucleotides ; b) per 1 part by mass of vitamin B2 or a derivative thereof or a salt thereof A drinking composition containing 0.02 to 2.5 parts by mass of propyl gallate and c) carbon dioxide at an internal gas pressure of 1.0 to 4.0 kg/cm 2 and packed in a capping container. 449nmの光透過率が0.1%以上である容器に充填した請求項1に記載の飲用組成物。 2. The drinking composition according to claim 1, packed in a container having a light transmittance of 0.1% or more at 449 nm.
JP2018183106A 2017-10-04 2018-09-28 drinking composition Active JP7279328B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017194514 2017-10-04
JP2017194514 2017-10-04

Publications (2)

Publication Number Publication Date
JP2019062888A JP2019062888A (en) 2019-04-25
JP7279328B2 true JP7279328B2 (en) 2023-05-23

Family

ID=66337280

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018183106A Active JP7279328B2 (en) 2017-10-04 2018-09-28 drinking composition

Country Status (1)

Country Link
JP (1) JP7279328B2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005304323A (en) 2004-04-19 2005-11-04 Ogawa & Co Ltd Method for preventing generation of odd smell component in vitamin b1-containing or its derivative-containing acidic beverage composition
JP2010143894A (en) 2008-12-22 2010-07-01 Ss Pharmaceut Co Ltd Oral solution medicine of reduced unpleasant taste and unpleasant odor
WO2013133408A1 (en) 2012-03-09 2013-09-12 武田薬品工業株式会社 Liquid medicine for internal use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3460089B2 (en) * 1991-12-10 2003-10-27 第一薬品工業株式会社 Internal liquids that prevent off-flavor generation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005304323A (en) 2004-04-19 2005-11-04 Ogawa & Co Ltd Method for preventing generation of odd smell component in vitamin b1-containing or its derivative-containing acidic beverage composition
JP2010143894A (en) 2008-12-22 2010-07-01 Ss Pharmaceut Co Ltd Oral solution medicine of reduced unpleasant taste and unpleasant odor
WO2013133408A1 (en) 2012-03-09 2013-09-12 武田薬品工業株式会社 Liquid medicine for internal use

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
20代夫婦が始めるご隠居生活 [オンライン], 2017.07.01 [検索日 2022.10.14], インターネット:<URL:https://nadegata.info/monster-high-pressure/>
Amazon [オンライン], 2008.03.07 [検索日 2022.10.14], インターネット:<URL:https://www.amazon.co.jp/%E3%83%81%E3%82%AA%E3%83%93%E3%82%BF-%E3%83%81%E3%82%AA%E3%83%93%E3%82%BF%E3%83%89%E3%83%AA%E3%83%B3%E3%82%AF-100ml%C3%9710%E6%9C%AC-%E6%8C%87%E5%AE%9A%E5%8C%BB%E8%96%AC%E9%83%A8%E5%A4%96%E5%93%81/dp/B0015LRAHY/ref=sr_1_1?__mk_ja_JP=%E3%82%AB%E3%82%BF%E3%82%AB%E3%83%8A&crid=2K6GOI41K61RB&keywords=%E3%83%81%E3%82%AA%E3%83%93%E3%82%BF%E3%83%89%E3%83%AA%E3%83%B3%E3%82%AF&,続きqid=1665713711&qu=eyJxc2MiOiIzLjE2IiwicXNhIjoiMi41NiIsInFzcCI6IjIuMzcifQ%3D%3D&sprefix=%E3%83%81%E3%82%AA%E3%83%93%E3%82%BF%E3%83%89%E3%83%AA%E3%83%B3%E3%82%AF%2Caps%2C415&sr=8-1>
Amazon [オンライン], 2015.06.04 [検索日 2022.10.12], インターネット:<URL:https://www.amazon.co.jp/%E3%83%AA%E3%83%9D%E3%83%93%E3%82%BF%E3%83%B3-%E5%A4%A7%E6%AD%A3%E8%A3%BD%E8%96%AC-%E3%83%AA%E3%83%9D%E3%83%93%E3%82%BF%E3%83%B3%E3%83%95%E3%82%A1%E3%82%A4%E3%83%B3-%E6%8C%87%E5%AE%9A%E5%8C%BB%E8%96%AC%E9%83%A8%E5%A4%96%E5%93%81-,続き100mLx10%E6%9C%AC/dp/B00YU235ZG/ref=sr_1_2?keywords=%E3%83%AA%E3%83%9D%E3%83%93%E3%82%BF%E3%83%B3%E3%83%95%E3%82%A1%E3%82%A4%E3%83%B3&qid=1665713649&qu=eyJxc2MiOiIzLjE5IiwicXNhIjoiMi40NSIsInFzcCI6IjIuMjkifQ%3D%3D&sr=8-2>
Hatena Blog [オンライン], 2010.05.07 [検索日 2022.10.14], インターネット:<URL:https://softcandy.hatenablog.com/entry/20100507/1273250160>
livedoor Blog [オンライン], 2006.03.13 [検索日 2022.10.12], インターネット:<URL:http://blog.livedoor.jp/masakani911/archives/50362022.html>
You Tube [オンライン], 2016.07.05 [検索日 2022.10.12], インターネット:<URL:https://www.youtube.com/watch?v=OlGTDgl4qTA>
クックパッド [オンライン], 2010.09.26 [検索日 2022.10.12], インターネット:<URL:https://cookpad.com/recipe/1200981>
ヤンマー部隊隊長の日記 [オンライン], 2011.02.22 [検索日 2022.10.12], インターネット:<URL:https://butaitaichou.com/entry/20110222/p1>
楽天レシピ [オンライン], 2014.06.04 [検索日 2022.10.14], インターネット:<URL:https://recipe.rakuten.co.jp/recipe/1090015576/>

Also Published As

Publication number Publication date
JP2019062888A (en) 2019-04-25

Similar Documents

Publication Publication Date Title
JP6443941B2 (en) Process for producing rebaudioside D sweet diet carbonated soft drink
JP2010045994A (en) Packed tea drink
JP7279328B2 (en) drinking composition
JP6087769B2 (en) Containerized beverage containing oolong tea extract
JP6429749B2 (en) Beverage containing enzyme-treated isoquercitrin
JP6191616B2 (en) Oral solution
JP2020162589A (en) Packaged beverage
JP5125146B2 (en) Oral solution
WO2020045562A1 (en) Stabilizer of pyrroloquinoline quinone, composition containing this, and stabilization method
JP6641175B2 (en) Caffeine-containing beverage containing methoxyflavone
JP5266644B2 (en) Ascorbic acid-containing liquid
JP2021165256A (en) Beverage composition
JP6528362B2 (en) Beverage
JP6087770B2 (en) Containerized beverage containing hexose sugar
JP4910428B2 (en) Oral solution composition
JP3597855B2 (en) Packaged beverage
WO2020230801A1 (en) Packaged beverage and method for improving preservation stability of isoxanthohumol
JP2023029277A (en) Packed beverage containing vitamin b1
JP2024025702A (en) Threonine-containing drinking composition
JP6323453B2 (en) Oral solution
JP2014207896A (en) Beverage
JP2021165255A (en) Beverage composition
WO2019009251A1 (en) Beverage
JP2010183911A (en) Beverage containing high-intensity sweetener

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210914

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221025

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221212

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230411

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230424

R150 Certificate of patent or registration of utility model

Ref document number: 7279328

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150